Editorial: Unravelling real-world impact of second-line therapies in primary biliary cholangitis- Time to change our targets?

Affiliations

• ¹ Division of Gastroenterology and Hepatology, Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
• ² Instituto Alfa de Gastroenterologia, Hospital das Clínicas da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
• ³ Division of Gastroenterology and Hepatology, Hospital da Polícia Militar de Minas Gerais, Belo Horizonte, Brazil.